New hope for hidden heart risk? drug trial targets silent blood flow problem
NCT ID NCT05711719
Summary
This study tested whether a drug called vericiguat could improve the function of tiny blood vessels in the heart for people with metabolic syndrome, a cluster of conditions like high blood pressure and high blood sugar. Forty-five participants were randomly assigned to receive either the drug or a placebo for about 6-10 weeks. Researchers used heart scans and blood tests to see if the drug helped the small arteries in the heart expand and allow better blood flow during stress.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METABOLIC SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Johns Hopkins Hospital
Baltimore, Maryland, 21287, United States
Conditions
Explore the condition pages connected to this study.